These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
77 related articles for article (PubMed ID: 9098685)
1. Anticonvulsant effects by combined treatment with a glycineB receptor antagonist and a polyamine site antagonist in amygdala-kindled rats. Ebert U; Wlaź P; Löscher W Eur J Pharmacol; 1997 Mar; 322(2-3):179-84. PubMed ID: 9098685 [TBL] [Abstract][Full Text] [Related]
2. Anticonvulsant effects of eliprodil alone or combined with the glycineB receptor antagonist L-701,324 or the competitive NMDA antagonist CGP 40116 in the amygdala kindling model in rats. Wlaź P; Ebert U; Löscher W Neuropharmacology; 1999 Feb; 38(2):243-51. PubMed ID: 10218865 [TBL] [Abstract][Full Text] [Related]
3. Weak anticonvulsant effects of two novel glycineB receptor antagonists in the amygdala-kindling model in rats. Wlaź P; Löscher W Eur J Pharmacol; 1998 Jan; 342(1):39-46. PubMed ID: 9544790 [TBL] [Abstract][Full Text] [Related]
4. Anticonvulsant effects of the glycine/NMDA receptor ligands D-cycloserine and D-serine but not R-(+)-HA-966 in amygdala-kindled rats. Löscher W; Wlaź P; Rundfeldt C; Baran H; Hönack D Br J Pharmacol; 1994 May; 112(1):97-106. PubMed ID: 8032669 [TBL] [Abstract][Full Text] [Related]
5. Anticonvulsant activity of antagonists and partial agonists for the NMDA receptor-associated glycine site in the kindling model of epilepsy. Rundfeldt C; Wlaź P; Löscher W Brain Res; 1994 Aug; 653(1-2):125-30. PubMed ID: 7982045 [TBL] [Abstract][Full Text] [Related]
6. LU 73068, a new non-NMDA and glycine/NMDA receptor antagonist: pharmacological characterization and comparison with NBQX and L-701,324 in the kindling model of epilepsy. Potschka H; Löscher W; Wlaź P; Behl B; Hofmann HP; Treiber HJ; Szabo L Br J Pharmacol; 1998 Nov; 125(6):1258-66. PubMed ID: 9863655 [TBL] [Abstract][Full Text] [Related]
7. Low doses of the glycine/NMDA receptor antagonist R-(+)-HA-966 but not D-cycloserine induce paroxysmal activity in limbic brain regions of kindled rats. Wlaź P; Ebert U; Löscher W Eur J Neurosci; 1994 Nov; 6(11):1710-9. PubMed ID: 7874310 [TBL] [Abstract][Full Text] [Related]
8. Differences in anticonvulsant potency and adverse effects between dextromethorphan and dextrorphan in amygdala-kindled and non-kindled rats. Löscher W; Hönack D Eur J Pharmacol; 1993 Jul; 238(2-3):191-200. PubMed ID: 8405092 [TBL] [Abstract][Full Text] [Related]
9. Effects of Nefiracetam, a novel pyrrolidone-type nootropic agent, on the amygdala-kindled seizures in rats. Kitano Y; Komiyama C; Makino M; Kasai Y; Takasuna K; Kinoshita M; Yamazaki O; Takazawa A; Yamauchi T; Sakurada S Epilepsia; 2005 Oct; 46(10):1561-8. PubMed ID: 16190926 [TBL] [Abstract][Full Text] [Related]
10. SIB 1893, a selective mGluR5 receptor antagonist, potentiates the anticonvulsant activity of oxcarbazepine against amygdala-kindled convulsions in rats. Borowicz KK; Łuszczki JJ; Czuczwar SJ Pol J Pharmacol; 2004; 56(4):459-64. PubMed ID: 15520501 [TBL] [Abstract][Full Text] [Related]
11. Anticonvulsant activity of felbamate in amygdala kindling model of temporal lobe epilepsy in rats. Wlaź P; Löscher W Epilepsia; 1997 Nov; 38(11):1167-72. PubMed ID: 9579916 [TBL] [Abstract][Full Text] [Related]
12. Effects of the competitive NMDA receptor antagonist, CGP 37849, on anticonvulsant activity and adverse effects of valproate in amygdala-kindled rats. Löscher W; Hönack D Eur J Pharmacol; 1993 Apr; 234(2-3):237-45. PubMed ID: 8097722 [TBL] [Abstract][Full Text] [Related]
13. Phenytoin's effect on the spread of seizure activity in the amygdala kindling model. Ebert U; Cramer S; Löscher W Naunyn Schmiedebergs Arch Pharmacol; 1997 Sep; 356(3):341-7. PubMed ID: 9303571 [TBL] [Abstract][Full Text] [Related]
14. Aminoglutethimide but not spironolactone enhances the anticonvulsant effect of some antiepileptics against amygdala-kindled seizures in rats. Borowicz KK; Czuczwar SJ J Neural Transm (Vienna); 2005 Jul; 112(7):891-903. PubMed ID: 15526139 [TBL] [Abstract][Full Text] [Related]
15. D-23129: a potent anticonvulsant in the amygdala kindling model of complex partial seizures. Tober C; Rostock A; Rundfeldt C; Bartsch R Eur J Pharmacol; 1996 May; 303(3):163-9. PubMed ID: 8813562 [TBL] [Abstract][Full Text] [Related]
16. Anticonvulsant and proconvulsant effects of inhibitors of GABA degradation in the amygdala-kindling model. Löscher W; Jäckel R; Müller F Eur J Pharmacol; 1989 Apr; 163(1):1-14. PubMed ID: 2744084 [TBL] [Abstract][Full Text] [Related]
17. The influence of strychnine-insensitive glycine receptor agonists and antagonists on generalized seizure thresholds. Croucher MJ; Bradford HF Brain Res; 1991 Mar; 543(1):91-6. PubMed ID: 1647257 [TBL] [Abstract][Full Text] [Related]
18. The effect of neuropeptide FF in the amygdala kindling model. Buffel I; Meurs A; Portelli J; Raedt R; De Herdt V; Poppe L; De Meulenaere V; Wadman W; Bihel F; Schmitt M; Vonck K; Bourguignon JJ; Simonin F; Smolders I; Boon P Acta Neurol Scand; 2016 Sep; 134(3):181-8. PubMed ID: 26503695 [TBL] [Abstract][Full Text] [Related]
19. Development and pharmacological suppression of secondary afterdischarges in the hippocampus of amygdala-kindled rats. Ebert U; Rundfeldt C; Löscher W Eur J Neurosci; 1995 Apr; 7(4):732-41. PubMed ID: 7620622 [TBL] [Abstract][Full Text] [Related]
20. Antiepileptogenic and anticonvulsant effects of NBQX, a selective AMPA receptor antagonist, in the rat kindling model of epilepsy. Namba T; Morimoto K; Sato K; Yamada N; Kuroda S Brain Res; 1994 Feb; 638(1-2):36-44. PubMed ID: 8199874 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]